Driving revenue growth and earnings growth are two different things.
Richard Saynor, Sandoz CEO, said, “This new state-of-the-art biosimilar development center in Ljubljana represents a major step up in our internal biosimilar development capabilities and is now a ...
While the regulatory landscape around biosimilars is evolving to encourage efficiency and innovation, the commercial ...
Chief Strategy Officer Balaji Prasad said the biosimilars-focused company is entering a “critical inflection period” as it ...
CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a wide variety of off-label indications and add hundreds of millions of dollars ...
Alvotech (NASDAQ:ALVO) shares climbed 12% in premarket trading on Thursday after the biotechnology company announced that the ...
WASHINGTON, DC - AUGUST 16, 2022: President Joe Biden (C) signs the Inflation Reduction Act with (L-R) Sen. Joe Manchin (D-WV), Senate Majority Leader Charles Schumer (D-NY), House Majority Whip James ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. As of today, July 1st, Cyltezo (adalimumab-adbm) is commercially ...
Within ten years, a patient may find that even a decades-old biologic treatment option they need has no other lower-cost alternative — and the one that’s available is prohibitively expensive and not ...
Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Biosimilar drugs (also known as biosimilars, or follow-on biologics) are almost identical versions of a medical product or a drug that are produced by a different company to the parent company. They ...
A key component of the Patient Protection and Affordable Care Act (PPACA) of 2010 has just been released with little fanfare. One of the most significant provisions in the law gives the Food and Drug ...